Buscar en
Archivos de la Sociedad Española de Oftalmología (English Edition)
Toda la web
Inicio Archivos de la Sociedad Española de Oftalmología (English Edition) Subretinal neovascular membrane in angioid streaks treated with intravitreal bev...
Journal Information
Vol. 89. Issue 5.
Pages 203-206 (May 2014)
Share
Share
Download PDF
More article options
ePub
Visits
2001
Vol. 89. Issue 5.
Pages 203-206 (May 2014)
Short communication
DOI: 10.1016/j.oftale.2014.07.007
Subretinal neovascular membrane in angioid streaks treated with intravitreal bevacizumab
Membrana neovascular subretiniana asociada a estrías angioides tratada con bevacizumab intravítreo
Visits
...
A. García-López
Corresponding author
albagarlo@hotmail.com

Corresponding author.
, C. González-Castaño
Servicio de Oftalmología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (5)
Show moreShow less
Abstract
Introduction

Angioid streaks are breaks in Bruch's membrane that may be associated, among others, with pseudoxanthoma elasticum. Its most common complication is the development of subretinal neovascular membranes (SRNVM) and the decreased vision this entails.

Case report

A 28-year-old woman with angioid streaks and SRNVM in the left eye, who received 3 injections of intravitreal bevacizumab, with rapid improvement in vision and stability during 11 months follow-up. The finding of angioid streaks led to the diagnosis of pseudoxanthoma elasticum.

Conclusion

Intravitreal bevacizumab should be considered as an effective treatment option for choroidal neovascularization associated with angioid streaks.

Keywords:
Angioid streaks
Pseudoxanthoma elasticum
Neovascular subretinal membrane
Anti-VEGF
Intravitreal bevacizumab
Resumen
Introducción

Las estrías angioides son roturas en la membrana de Bruch que pueden asociarse, entre otras, a pseudoxantoma elástico. Su complicación más frecuente es el desarrollo de membranas neovasculares subretinianas (MNVSR) con la disminución de visión que conlleva.

Caso clínico

Mujer de 28 años con estrías angioides y MNVSR en ojo izquierdo, que recibió tres inyecciones de bevacizumab intravítreo, con rápida mejoría de la visión y estabilidad durante 11 meses de seguimiento. El hallazgo de estrías angioides permitió el diagnóstico de pseudoxantoma elástico.

Conclusión

El bevacizumab intravítreo debe ser considerado como una opción terapéutica eficaz para la neovascularización coroidea asociada a estrías angioides.

Palabras clave:
Estrías angioides
Pseudoxantoma elástico
Membrana neovascular subretiniana
Anti-VEGF
Bevacizumab intravítreo

Article

These are the options to access the full texts of the publication Archivos de la Sociedad Española de Oftalmología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de la Sociedad Española de Oftalmología (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos